Pfizer Investor Suit Hits Roadblock As Expert Report Tossed
A long-running securities class action alleging Pfizer Inc. hid health risks associated with painkiller drugs faces an uncertain future after a New York federal judge threw out a crucial damages report...To view the full article, register now.
Already a subscriber? Click here to view full article